Showing results (331-340 of 661) with videos related to
Sort By:
Pageof 67
Cancer Prevention Research (Philadelphia, Pa.)|August 23, 2012
Loss of heterozygosity (LOH) profiles--validated risk predictors for progression to oral cancerLewei Zhang, Catherine F Poh, Michele Williams, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 26, 2004
Tetranucleotide microsatellite instability in surgical margins for prediction of local recurrence of head and neck squamous cell carcinomaStephane Temam, Odile Casiraghi, Jean-Baptiste Lahaye, et al.Cancer|October 26, 2005
Akt activation correlates with adverse outcome in tongue cancerErminia Massarelli, Diane D Liu, J Jack Lee, et al.Cancer Research|December 18, 2015
Modulation of EZH2 Expression by MEK-ERK or PI3K-AKT Signaling in Lung Cancer Is Dictated by Different KRAS Oncogene MutationsErick Riquelme, Carmen Behrens, Heather Y Lin, et al.Brain Communications|July 5, 2021
Machine-learning method for localization of cerebral white matter hyperintensities in healthy adults based on retinal imagesBenny Zee, Yanny Wong, Jack Lee, et al.Experimental and Therapeutic Medicine|September 15, 2012
Frequent expression of MAGE1 tumor antigens in bronchial epithelium of smokers without lung cancerManisha Bhutani, Ashutosh Kumar Pathak, Hongli Tang, et al.Cancer|January 25, 2005
Loss of E-cadherin and p27 expression is associated with head and neck squamous tumorigenesisErminia Massarelli, Erika Brown, Ngoc K Tran, et al.Journal of Cardiovascular Translational Research|March 17, 2019
Intra-aortic Balloon Counterpulsation for High-Risk Percutaneous Coronary Intervention: Defining Coronary RespondersNatalia Briceno, Kalpa De Silva, Matthew Ryan, et al.Endocrinology, Diabetes & Metabolism Case Reports|February 22, 2025
Resistant hypertension post-transsphenoidal surgery for pituitary Cushing's disease, leading to a diagnosis of primary aldosteronismJack Lee, Maria Tomkins, Darran McDonald, et al.American Journal of Clinical Oncology|February 6, 2009
Phase I trial of weekly topotecan and gemcitabine in patients with solid tumorsWilliam N William, Joseph L Lee, Dong M Shin, et al.Pageof 67